about
A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patientsClinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin.Reflectance confocal microscopy for in vivo skin imaging.The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy.Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation.Guidelines on the use of extracorporeal photopheresisArterial Tortuosity Syndrome: homozygosity for two novel and one recurrent SLC2A10 missense mutations in three families with severe cardiopulmonary complications in infancy and a literature review.Persistence of human T cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides.Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.Photodynamic therapy: update 2006. Part 2: Clinical results.Merkel cell carcinoma and HIV infection: a case report and review of the literature.Photodynamic antifungal chemotherapy.Dermatofibrosarcoma protuberans in an adolescent: a case report and review of the literature.Matter of margins.The nested graft acts by inducing the process of de-senescence of the fibroblasts in chronic venous ulcers.Vismodegib in the treatment of basal cell carcinoma: indications for clinical practice.Insights in the etiopathology of galactosyltransferase II (GalT-II) deficiency from transcriptome-wide expression profiling of skin fibroblasts of two sisters with compound heterozygosity for two novel B3GALT6 mutations.Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face study.Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of polymorphic light eruption.Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides.Histopathological study of perilesional skin in patients diagnosed with nonmelanoma skin cancer.Flow cytometric quantification of UV-induced cell death in a human squamous cell carcinoma-derived cell line: dose and kinetic studies.Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients.Perspectives in cutaneous photodynamic sensitization.Photodynamic therapy with systemic administration of photosensitizers in dermatology.Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.Risk of oral cavity malignancies in patients with cutaneous melanoma.Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system.Photosensitive erythema multiforme and erythema multiforme-like polymorphous light eruption.Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex.Allergic contact dermatitis from nickel in a piezoelectrical device for mosquito bites ('Click').Lymphomatoid allergic contact dermatitis from para-phenylenediamine.Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel.Compound heterozygosity of the novel -186C>T mutation in the COL7A1 promoter and the recurrent c.497insA mutation leads to generalized dystrophic epidermolysis bullosa.Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid.
P50
Q28289813-2CE0B79C-EDE1-4609-9AB1-92952EF30EA2Q33274711-F5926AEB-FE08-4B2F-8E35-12F6AACBF59FQ33391553-50CDD013-32AD-4587-8285-B580A309AFB6Q33646654-F5A1A22D-A1B5-4D66-9796-EAAB1DCF6DBEQ34538127-E8E4B1E2-009C-43B7-A62D-9912476CF502Q34918643-3DEB80C4-8BA3-483C-A669-5BAE4E7B9172Q35397090-6607A8E8-9DE2-4CE4-9329-D770E348895EQ36363979-231F0BB9-0972-40D1-9E59-8574DA9AF202Q36669286-C495528B-5D37-4418-8D0E-4A86D2B8DE0DQ36764960-35D2D5FA-BFE3-4D92-9832-9367447D4337Q36890868-44C2A2B4-7387-48FB-8599-A53E8B60516EQ37982147-6F0C3312-455B-4560-815D-E55B6ABF7D26Q38093025-487B5F54-6BAB-447F-A055-A92EEA87699FQ38235224-7A5884C6-4678-430A-A4C7-71B0C2889525Q38388036-A5A1034D-CB67-4C52-A19B-AB2617453789Q38465861-EA51588D-8869-4D72-AB0A-6986EB245311Q38470441-5B67530F-2843-4D0C-8950-13FADB850E5AQ39042790-893790BB-A10C-4539-9730-02DCAF36A3ADQ39346077-B278163E-CA70-4CD9-B483-FB09C0BA4137Q39509317-E68D16C0-FC48-4240-A090-F74BB1B610D5Q40564723-BC957DC0-B601-43E9-BF2C-FA771066C7ADQ40720711-47F7D63E-CB19-48B6-8961-6F54D29BD49AQ41005370-92554F59-1352-424D-8916-9E143ADDC4F2Q41035413-B38B1A11-6DFD-483D-83DA-9F9676FFD8BDQ41322927-59B834C5-4F74-4330-A50B-3FA13EDB009AQ41322961-2AD27E13-77E0-4DA8-B914-F7E722A1971BQ41938203-BE8D6E80-2E34-4CCF-8C78-1B153C561A8DQ42479516-6154F0A1-CE9B-476E-828D-E8F5DA696EA9Q42497819-486C7B06-13A5-4322-9AB7-611FEFFC64BFQ42513271-C66E59FB-2F12-417A-837F-CBA3334E9E8FQ42520555-96417167-0F75-4589-B13E-160B2467D47EQ42648167-B26B2621-5B38-486D-BC8B-D963C0AEABE7Q43531310-54EB64EC-FC1D-43BB-83BE-C1A3BF6118F8Q43877667-1793B3E3-D61E-4222-890F-B130D7458187Q44140598-F73DB431-5DDC-4C35-9E26-F969BF20445BQ44256327-88E3AD59-C989-4295-A7E5-D0C6092D7C9DQ44292015-979FAD60-4645-4515-9B19-3977226B1AE7Q44477550-59B5879F-C60A-49C5-BAF3-BB4F493ABCBCQ44500682-C85EDAED-82C0-485F-81A6-29B3F38ACE7DQ44896741-F80F35E9-FD5F-4E17-984B-FD82A90DEF8D
P50
description
researcher ORCID ID = 0000-0002-0935-7204
@en
wetenschapper
@nl
name
Piergiacomo Calzavara-Pinton
@ast
Piergiacomo Calzavara-Pinton
@en
Piergiacomo Calzavara-Pinton
@es
Piergiacomo Calzavara-Pinton
@nl
type
label
Piergiacomo Calzavara-Pinton
@ast
Piergiacomo Calzavara-Pinton
@en
Piergiacomo Calzavara-Pinton
@es
Piergiacomo Calzavara-Pinton
@nl
prefLabel
Piergiacomo Calzavara-Pinton
@ast
Piergiacomo Calzavara-Pinton
@en
Piergiacomo Calzavara-Pinton
@es
Piergiacomo Calzavara-Pinton
@nl
P1153
7006103486
P31
P496
0000-0002-0935-7204